Ana J. Caillava
General San Martin, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A vaccine candidate based on baculovirus displaying chikungunya virus E1-E2 envelope confers protection against challenge in mice.
Journal: Journal of virology
Published: October 23, 2024
Development of a set of bacterial engineered glycoconjugates as novel serogroup-specific antigens for the serodiagnosis of Escherichia coli O26, O111, O103 and O45 infections associated to hemolytic uremic syndrome.
Journal: Microbial cell factories
Published: October 02, 2024
Development of a scalable recombinant system for cyclic beta-1,2-glucans production.
Journal: Microbial cell factories
Published: October 03, 2023
Development of a novel glycoprotein-based immunochromatographic test for the rapid serodiagnosis of bovine brucellosis.
Journal: Journal of applied microbiology
Published: May 22, 2021
Improving bioreactor production of a recombinant glycoprotein in Escherichia coli: Effect of specific growth rate on protein glycosylation and specific productivity.
Journal: Biotechnology and bioengineering
Published: October 18, 2018
A Bacterial Glycoengineered Antigen for Improved Serodiagnosis of Porcine Brucellosis.
Journal: Journal of clinical microbiology
Published: January 22, 2016
Electrochemical magnetic microbeads-based biosensor for point-of-care serodiagnosis of infectious diseases.
Journal: Biosensors & bioelectronics
Published: November 23, 2015
Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.
Journal: Journal of clinical microbiology
Published: December 05, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026